Boletin INFAC: racionalidad en el tratamiento de las dislipemias


Boletin INFAC: racionalidad en el tratamiento de la dislipemias. Trabajo de Excellencis y Gapurmed.

infac_vol19_n5http://d1.scribdassets.com/ScribdViewer.swf?document_id=58914892&access_key=key-1kir6hhh2fosevdijjwt&page=1&viewMode=list

This entry was posted in Boletin INFAC, dislipemias, Excellencis, GAPURMED, Uso Racional del Medicamento. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s